Gummer, J., Trengove, R., Pascoe, E., Badve, S., Cass, A., Clarke, P., . . . Ferrari, P. (2017). Association between serum hepcidin-25 and primary resistance to erythropoiesis-stimulating agents in chronic kidney disease: A secondary analysis of the HERO trial. Wiley-Blackwell.
Chicago Style (17th ed.) CitationGummer, J., et al. Association Between Serum Hepcidin-25 and Primary Resistance to Erythropoiesis-stimulating Agents in Chronic Kidney Disease: A Secondary Analysis of the HERO Trial. Wiley-Blackwell, 2017.
MLA (9th ed.) CitationGummer, J., et al. Association Between Serum Hepcidin-25 and Primary Resistance to Erythropoiesis-stimulating Agents in Chronic Kidney Disease: A Secondary Analysis of the HERO Trial. Wiley-Blackwell, 2017.
Warning: These citations may not always be 100% accurate.